» Authors » Ewa Paszkiewicz-Kozik

Ewa Paszkiewicz-Kozik

Explore the profile of Ewa Paszkiewicz-Kozik including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 39
Citations 307
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Kalicinska E, Jablonowska-Babij P, Morawska M, Iskierka-Jazdzewska E, Drozd-Sokolowska J, Paszkiewicz-Kozik E, et al.
EJHaem . 2025 Jan; 6(1):e1042. PMID: 39866935
Background: Patients with chronic lymphocytic leukemia (CLL) are susceptible to infections that can affect their clinical outcomes. Aims: To assess: (1) the incidence of pneumonia in CLL patients treated with...
2.
Kalicinska E, Jablonowska-Babij P, Morawska M, Iskierka-Jazdzewska E, Drozd-Sokolowska J, Paszkiewicz-Kozik E, et al.
Cancers (Basel) . 2025 Jan; 16(24. PMID: 39766067
Background/objectives: Patients with chronic lymphocytic leukemia (CLL) are susceptible to infections that can affect their clinical outcomes. Aims: The aims of this study were to assess the following: (1) the...
3.
Kulecka M, Czarnowski P, Balabas A, Turkot M, Kruczkowska-Tarantowicz K, Zeber-Lubecka N, et al.
Int J Mol Sci . 2024 Aug; 25(15). PMID: 39125593
The key association between gut dysbiosis and cancer is already known. Here, we used whole-genome shotgun sequencing (WGS) and gas chromatography/mass spectrometry (GC/MS) to conduct metagenomic and metabolomic analyses to...
4.
Glinka P, Sobstyl M, Rymkiewicz G, Wierzba-Bobrowicz T, Paszkiewicz-Kozik E, Grajkowska W
Folia Neuropathol . 2024 May; 62(1):102-107. PMID: 38741437
MALT lymphoma of the dura is a very rare type of low-grade B-cell lymphoma. Little more than 100 cases have been reported in the literature to date. We report a...
5.
Sosnia O, Pruszczyk K, Danecki M, Wasik-Szczepanek E, Tryc-Szponder J, Iskierka-Jazdzewska E, et al.
Leuk Lymphoma . 2023 Nov; 65(2):175-186. PMID: 37921067
Richter transformation (RT) is defined as developing an aggressive lymphoma in 2-10% of patients suffering from chronic lymphocytic leukemia (CLL). So far, no complex analysis of RT demographics and treatment...
6.
Sobon A, Drozd-Sokolowska J, Paszkiewicz-Kozik E, Poplawska L, Morawska M, Tryc-Szponder J, et al.
Ann Hematol . 2023 Jul; 102(8):2119-2126. PMID: 37392368
The results of the MURANO trial showed encouraging progression-free survival (PFS) and overall survival (OS) in relapsed/refractory chronic lymphocytic leukemia (RR-CLL) patients treated with venetoclax-rituximab (VEN-R). A retrospective analysis was...
7.
Sadaf H, Ambroziak M, Binkowski R, Kluebsoongnoen J, Paszkiewicz-Kozik E, Steciuk J, et al.
Front Immunol . 2023 Jun; 14:1155468. PMID: 37266436
Recent discoveries shed light on molecular mechanisms responsible for classical Hodgkin lymphoma (HL) development and progression, along with features of Hodgkin - Reed and Sternberg cells (HRS). Here, we summarize...
8.
Ostrowska B, Domanska-Czyz K, Romejko-Jarosinska J, Osowiecki M, Targonski L, Poplawska L, et al.
Br J Haematol . 2023 Feb; 201(4):663-672. PMID: 36762710
Clinical data on primary central nervous system (CNS) lymphoma (PCNSL) patients is mostly generated from prospective studies, and many frail real-world patients are not included. Recently,the diagnosis and treatment of...
9.
Paszkiewicz-Kozik E, Hus I, Palka M, Debowska M, Konska A, Kotarska M, et al.
Adv Clin Exp Med . 2023 Jan; 32(1):131-136. PMID: 36603138
Background: The first-line obinutuzumab-based immunochemotherapy improves the outcome of patients with follicular lymphoma (FL) compared with rituximab-based regimens. However, infusion-related reactions occur in almost half of patients during the 1st...
10.
Kalicinska E, Giza A, Zaucha J, Giebel S, Zimowska-Curylo D, Andrasiak I, et al.
Cancer Med . 2022 Sep; 12(3):3036-3045. PMID: 36161781
Objective: To investigate the prevalence of histopathological subtypes, the clinical stage at presentation and treatment modalities in Polish patients with orbital lymphoma (OL) and to determine prognostic outcomes. Methods: The...